MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03899nam a22003017a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20241101105632.0 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241101110315.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241101b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-3-030-76262-9 |
|
|---|
| International Standard Book Number |
978-3-030-76263-6 (eBook) |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
2523-8027 |
|
|---|
| International Standard Serial Number |
2523-8035 (electronic) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
ddc |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Muthupandian Saravanan |
| 222 ## - KEY TITLE |
|---|
| Key title |
acid activity Advanced apoptosis applications biocompatibility biological Biomaterials brain breast cancer cancer cells Cancer Nanotheranostics cancer theranostics cancer therapy carbon nanotubes carriers cell lines cellular chemical Chemistry chemotherapeutic chemotherapy Chen chitosan clinical trials conjugated contrast agents Controlled Release cytotoxicity delivery systems dendrimer detection diagnosis disease DNA doxorubicin drug delivery drug release effects efficacy efficient encapsulated enhanced evaluation FDA Fig fluorescence formulation functional gene gold nanoparticles graphene H https://doi https://www imaging International Journal iron oxide ligands lipid liposomes Liu magnetic Materials medicine membrane method micelles microswimmers molecular molecules MRI MTT assay multifunctional nanobiomaterials nanocarriers nanoformulations nanomaterials Nanomedicine nanoparticles nanoplatforms Nanoscale nanostructures Nanotechnology nanotheranostic agent Nanotoxicology near-infrared NIR nm NPs oxide nanoparticles paclitaxel particle patients PDT peptide photodynamic therapy photothermal therapy PLGA polymer polymeric potential protein PTT receptor Research safety silver nanoparticles Spherical studies surface synthesis targeting techniques theranostic therapeutic tion tissues toxicity treatment tumor uptake vitro vivo Wang Zhang. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Cancer Nanotheranostics. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Department of Pharmacology Saveetha Dental College Saveetha Institute of Medical and Technical Sciences (SIMATS) Chennai, India | |
| Name of publisher, distributor, etc. |
Springer Nature Switzerland AG | |
| Date of publication, distribution, etc. |
2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
379 Pages |
|
|---|
| Extent |
Includes References |
| 490 ## - SERIES STATEMENT |
|---|
| Series statement |
Nanotechnology in the Life Sciences |
| Volume/sequential designation |
Volume 2 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Cancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows.<br/><br/>In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies.<br/><br/>This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics.<br/><br/>Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| General subdivision |
Cancer, Medical / General, Medical / Oncology / General, Nanobiotechnology, Nanomedicine, Science / Biotechnology, Technology & Engineering / Materials Science / General, Biotechnology, Cancer -- Research, Cancer -- Treatment -- Technological innovations -- Diagnosis, Electronic books, Materials science, Nanostructured materials. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Hamed Barabadi |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href=" https://doi.org/10.1007/978-3-030-76263-6 "> https://doi.org/10.1007/978-3-030-76263-6 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
| Suppress in OPAC |
|
